Loading company…
Orgentec Diagnostika GmbH develops immunodiagnostic assays for autoimmune and infectious diseases and is part of the Sebia Group.
Based in Mainz, Germany, and founded in 1988, Orgentec Diagnostika GmbH makes immunodiagnostic assays for autoimmune and infectious diseases, used by laboratories, hospitals and research institutions in Europe, North America and parts of Asia. Sebia S.A. acquired the company from Water Street Healthcare Partners in June 2021. Its CEO is Isidoro Perez. It reported revenue of USD 37.22 mn for fiscal 2022 and EBITDA of USD 10.41 mn in 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in